"Altretamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A hexamethyl-2,4,6-triamine derivative of 1,3,5-triazine.
| Descriptor ID |
D006585
|
| MeSH Number(s) |
D03.383.931.135
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Altretamine".
Below are MeSH descriptors whose meaning is more specific than "Altretamine".
This graph shows the total number of publications written about "Altretamine" by people in this website by year, and whether "Altretamine" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Altretamine" by people in Profiles.
-
A 10-year experience with combined modality therapy for stage III small cell lung carcinoma. Cancer. 1986 Nov 15; 58(10):2177-84.
-
Hexamethylmelamine, cyclophosphamide, adriamycin, cis-platinum chemotherapy as initial and second-line treatment of advanced ovarian carcinoma. Oncology. 1986; 43(1):12-7.
-
The effect of lithium carbonate on chemotherapy-induced neutropenia and thrombocytopenia. Am J Hematol. 1984 May; 16(4):313-23.
-
Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine. Cancer Treat Rep. 1978 Apr; 62(4):567-9.